Contact us at 914-666-4665

Dr. Daniel Cameron

Board-certified physician with 38+ years specializing in Lyme disease and tick-borne illnesses. Past President of ILADS (International Lyme and Associated Diseases Society) and first author of ILADS treatment guidelines. Dr. Cameron operates a solo practice focused on patient advocacy and evidence-based Lyme disease treatment. He is the author of 1,100+ articles spanning diagnosis, treatment, co-infections, and recovery from tick-borne illnesses. His work challenges conventional approaches that often leave patients undiagnosed or undertreated, emphasizing clinical judgment over rigid adherence to testing criteria that frequently produce false negatives.

Dr. Daniel Cameron
Different response by CDC to spread of Zika virus vs. Lyme disease-carrying ticks

Lyme Disease CDC Response vs Zika: A Public Health Gap

Lyme Disease CDC Response vs Zika: A Public Health Gap The Lyme disease CDC response has not matched the urgency seen with other emerging infectious threats. While both Lyme disease and Zika virus can lead to serious long-term health complications, the public health response to these conditions has differed significantly. :contentReference[oaicite:0]{index=0} The CDC responded to […]

Lyme Disease CDC Response vs Zika: A Public Health Gap Read More »

Lyme Disease Cognitive Impairment: Persistent Effects After Stroke

Lyme Disease Cognitive Impairment: Persistent Effects After Stroke Lyme disease cognitive impairment can persist even after treatment and recovery from acute complications. A growing body of research suggests that infectious agents may contribute to long-term cognitive decline. :contentReference[oaicite:0]{index=0} A study by Nimgaonkar and colleagues found that exposure to infectious agents—including CMV, HSV-1, HSV-2, and Toxoplasma

Lyme Disease Cognitive Impairment: Persistent Effects After Stroke Read More »

Limits on antibiotics for Lyme disease leave doctors in Limbo

Limits on Antibiotics for Lyme Disease: Why Doctors Are in Limbo

Limits on Antibiotics for Lyme Disease: Why Doctors Are in Limbo Limits on antibiotics for Lyme disease leave many patients and physicians navigating uncertainty when symptoms persist. As many as one-third of patients remain ill on long-term follow-up, with ongoing arthritis, neurocognitive impairment, and neurologic complications. :contentReference[oaicite:0]{index=0} A population-based study in Massachusetts found that 34%

Limits on Antibiotics for Lyme Disease: Why Doctors Are in Limbo Read More »

Patients should be warned of Lyme disease complications, including Lyme encephalopathy

Lyme Encephalopathy Symptoms: Why Patients Should Be Warned

Lyme Encephalopathy Symptoms: Why Patients Should Be Warned Lyme encephalopathy symptoms—including memory loss and cognitive impairment—are well documented in the medical literature. Yet some clinicians continue to question whether this condition exists, raising concerns about patient awareness and diagnosis. :contentReference[oaicite:0]{index=0} A review by Wormser and colleagues stated that they had “never seen the poorly defined

Lyme Encephalopathy Symptoms: Why Patients Should Be Warned Read More »

Google searches on Lyme disease jump to their highest level

Lyme Disease Search Trends: Global Awareness Surges in 2015

Lyme Disease Search Trends: Global Awareness Surges in 2015 Italy. Google Search Trends on Lyme disease. 2011 – 2015. Lyme disease search trends reached their highest levels in 2015, reflecting a major surge in global awareness. Media coverage, celebrity disclosures, and advocacy efforts brought unprecedented attention to the disease. :contentReference[oaicite:0]{index=0} High-profile individuals—including Yolanda Foster, Avril

Lyme Disease Search Trends: Global Awareness Surges in 2015 Read More »

babesia awareness

Babesia Awareness: What Connecticut Residents Don’t Know

Babesia Awareness: What Connecticut Residents Don’t Know Babesia awareness is dangerously low—even in areas where the disease is common. A Connecticut survey found that only 23% of residents knew deer ticks can transmit Babesia, despite living in one of the most endemic regions in the country. :contentReference[oaicite:0]{index=0} The results were published in Ticks and Tick-borne

Babesia Awareness: What Connecticut Residents Don’t Know Read More »

Lyme Disease Pandemic: Is It Time for Reclassification?

Lyme Disease Pandemic: Is It Time for Reclassification? Lyme disease pandemic concerns are growing as cases expand geographically and affect large populations. Data from Connecticut alone illustrate the scale of the problem, with thousands of new diagnoses each year and a significant proportion of families affected. :contentReference[oaicite:0]{index=0} In 2004, Connecticut’s chief epidemiologist, Dr. James Hadler,

Lyme Disease Pandemic: Is It Time for Reclassification? Read More »

25th anniversary of first study describing chronic neurologic Lyme disease

Chronic Neurologic Lyme Disease: 25 Years After a Landmark Study

Chronic Neurologic Lyme Disease: 25 Years After a Landmark Study Chronic neurologic Lyme disease can lead to persistent cognitive and neurologic symptoms long after infection. A landmark study published in the New England Journal of Medicine first described these chronic manifestations and continues to influence clinical understanding today. :contentReference[oaicite:0]{index=0} The 1990 study by Logigian, Kaplan,

Chronic Neurologic Lyme Disease: 25 Years After a Landmark Study Read More »

Top Lyme and tick-borne disease stories of 2015

Top Lyme Disease News Stories of 2015

Top Lyme Disease News Stories of 2015 Lyme disease news in 2015 reflected a major shift in awareness, research, and public engagement. From increased funding to celebrity advocacy and emerging scientific insights, the year marked an important moment in the evolution of Lyme disease recognition. :contentReference[oaicite:0]{index=0} Here are some of the most important Lyme and

Top Lyme Disease News Stories of 2015 Read More »

Culture evidence of Lyme disease in antibiotic treated patients living in the Southeast

Seronegative Lyme Disease: Culture Evidence After Antibiotic Treatment

Seronegative Lyme Disease: Culture Evidence After Antibiotic Treatment Geographic Expansion into the Southeast Seronegative Lyme disease may be more common than recognized, particularly as Lyme disease expands geographically. Scientists are increasingly focusing their attention on identifying tick-borne pathogens present in the Southeastern United States. :contentReference[oaicite:0]{index=0} In 2015, Lantos and colleagues reviewed the geographic expansion of

Seronegative Lyme Disease: Culture Evidence After Antibiotic Treatment Read More »